T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Nabors Industries
NBR
$1.33B
| $984K | ﹤0.01% |
18,116
-8,049
| -31% | -$392K |
|
2077
WisdomTree US MidCap Fund
EZM
$960M
| $979K | ﹤0.01% |
14,651
| – | – |
|
2078
Live Oak Bancshares
LOB
$1.98B
| $979K | ﹤0.01% |
28,476
-5,200
| -15% | -$174K |
|
2079
Buckle
BKE
$2.33B
| $978K | ﹤0.01% |
18,306
+1,396
| +8% | +$77.8K |
|
2080
Vitesse Energy
VTS
$685M
| $978K | ﹤0.01% |
50,740
+16,487
| +48% | +$352K |
|
|
NLOP
2081
Net Lease Office Properties
NLOP
$171M
| $972K | ﹤0.01% |
37,658
+12,743
| +51% | +$360K |
|
2082
Astronics
ATRO
$4.57B
| $971K | ﹤0.01% |
21,467
+1,707
| +9% | +$71.6K |
|
2083
Arvinas
ARVN
$580M
| $968K | ﹤0.01% |
81,565
-5,751
| -7% | -$62.8K |
|
2084
Fidelity MSCI Information Technology Index ETF
FTEC
$21.6B
| $967K | ﹤0.01% |
4,302
| – | – |
|
2085
PACS Group
PACS
$7.2B
| $967K | ﹤0.01% |
25,184
+1,829
| +8% | +$40.1K |
|
2086
Liberty Latin America Class C
LILAK
$1.67B
| $964K | ﹤0.01% |
142,056
+13,196
| +10% | +$98.7K |
|
2087
Utz Brands
UTZ
$1.25B
| $964K | ﹤0.01% |
92,780
+16,437
| +22% | +$177K |
|
2088
Green Dot
GDOT
$766M
| $960K | ﹤0.01% |
74,876
| – | – |
|
2089
Orthofix Medical
OFIX
$415M
| $959K | ﹤0.01% |
63,245
+16,556
| +35% | +$253K |
|
2090
Shore Bancshares
SHBI
$801M
| $957K | ﹤0.01% |
54,120
+9,641
| +22% | +$162K |
|
|
DAWN
2091
DELISTED
Day One Biopharmaceuticals
DAWN
| $955K | ﹤0.01% |
102,456
+22,723
| +28% | +$190K |
|
2092
iShares MSCI South Korea ETF
EWY
$27.6B
| $953K | ﹤0.01% |
+9,797
| New | +$895K |
|
|
TWO
2093
Two Harbors Investment
TWO
$1.27B
| $952K | ﹤0.01% |
90,647
-25,173
| -22% | -$252K |
|
|
TWFG
2094
TWFG Inc
TWFG
$1.46B
| $950K | ﹤0.01% |
33,018
+1,800
| +6% | +$48.9K |
|
2095
Brown-Forman Class A
BF.A
$13B
| $948K | ﹤0.01% |
36,000
| – | – |
|
|
BFS
2096
Saul Centers
BFS
$850M
| $948K | ﹤0.01% |
30,055
+5,657
| +23% | +$174K |
|
2097
Adtran
ADTN
$665M
| $945K | ﹤0.01% |
108,727
+3,299
| +3% | +$28.6K |
|
2098
VanEck Semiconductor ETF
SMH
$72.5B
| $937K | ﹤0.01% |
2,600
-50
| -2% | -$17.5K |
|
2099
DHT Holdings
DHT
$3.09B
| $934K | ﹤0.01% |
76,466
+8,424
| +12% | +$106K |
|
2100
MVB Financial
MVBF
$397M
| $934K | ﹤0.01% |
36,153
+1,120
| +3% | +$29.7K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.